With rapid advancements in neurological and neuropsychiatric research, the need for advanced tools for scientists is growing significantly. Neurescence is an agile, innovative startup providing the most advanced optical imaging technologies to address the most rigorous neuroscience needs. Neurescence is pleased to announce its new distribution sales partnership with Plexon Inc. Plexon provides solutions for data acquisition, behavioral research and advanced analysis designed specifically for neuroscience research.
Neurescence’s proprietary multiscopes™, including the Quartet® and Chromatone™, enable multi-region and multi-colour functional imaging within the brain and spinal cord in freely behaving animals. The technology enables study of both local and long range neuronal circuits within the central nervous system. Neurescence products have the potential to help researchers make an impact through fundamental understanding of neuronal interaction leading to deep insight relative to diseases such as Parkinson’s, Alzheimer’s and Epilepsy.
Through this partnership, Plexon will be a non-exclusive distributor of Neurescence products, broadening use within academic labs and research facilities throughout North America.
“Neurescence is delighted to team up with Plexon in our efforts to advance neuroscience research. Plexon’s experience and extensive network and reach to over 3800 laboratories complements our goal of providing researchers with a product designed to advance in their scientific discoveries,” says Yasaman Soudagar, co-Founder and CEO of Neurescence.
Harvey Wiggins, President and Founder of Plexon commented “Neurescence is a company dedicated to neuroscience research and outstanding customer support, which are both important foundations of Plexon. The systems from Neurescence fit exceptionally well within the suite of recording and imaging systems available from Plexon.”
Plexon is a pioneer and leading innovator of custom high performance solutions for data acquisition, behavioral research and advanced analysis specifically devised for neuroscience research. Their equipment and solutions lay the foundation for work performed around the globe in fields such as basic science, Brain-Machine Interfaces (BMI), neurodegenerative diseases, addictive behaviors and neuroprosthetics.
Neurescence was founded in 2015 by a team of scientists and medical professionals with the goal of finding better treatments for diseases of the central nervous system through advancing scientific research. The company combines its novel optical imaging technology with machine learning to overcome critical medicinal and clinical challenges for overcoming neurological and psychiatric conditions. The partnership with Plexon is a major step that expedites Neurescence’s path to fulfill its vision.